Mucins in ovarian cancer diagnosis and therapy
<p>Abstract</p> <p>Ovarian cancer is the most lethal gynecologic malignancy and the five-year survival rate is only 35% after diagnosis. Epithelial ovarian cancer is a highly metastatic disease characterized by widespread peritoneal dissemination and ascites. The death incidences f...
Saved in:
Main Authors: | Chauhan Subhash C (Author), Kumar Deepak (Author), Jaggi Meena (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2009-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
by: Zaman Mohd Saif, et al.
Published: (2012) -
Scope of nanotechnology in ovarian cancer therapeutics
by: Yallapu Murali M, et al.
Published: (2010) -
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy
by: Shabnam Malik, et al.
Published: (2024) -
Chapter Demographic and Clinical Characteristics of Mucinous Epithelial Ovarian Cancer, and Survival Following a Mucinous Epithelial Ovarian Cancer Diagnosis
by: O'Malley, Cynthia D.
Published: (2013) -
Chapter Demographic and Clinical Characteristics of Mucinous Epithelial Ovarian Cancer, and Survival Following a Mucinous Epithelial Ovarian Cancer Diagnosis
by: O'Malley, Cynthia D.
Published: (2013)